​

Radiopharm Theranostics Ownership | Who Owns Radiopharm Theranostics?

OverviewRevenueFinancialsChart

Radiopharm Theranostics Ownership Summary

Radiopharm Theranostics is owned by 739.64% institutional investors.

RADX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockRadiopharm Theranostics739.64%--639.64%
SectorHealthcare Stocks 35.75%11.89%52.37%
IndustryBiotech Stocks 36.05%11.82%52.13%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20267-36.36%51,308,037-0.45%7390.13%1-85.71%3200.00%
Dec 31, 202511175.00%51,539,57716392.35%7423660.90%7250.00%1-
Sep 30, 20254-20.00%312,506-8.00%418.79%2---100.00%
Jun 30, 2025566.67%339,690-0.94%420.04%2-1-
Mar 31, 20253-25.00%342,915-21.31%412.53%--100.00%1-

Insider Transactions Trends

DateBuySell
2028 Q3--
2026 Q1--

RADX Ownership FAQ

Who Owns Radiopharm Theranostics?

Radiopharm Theranostics shareholders are primarily institutional investors at 739.64%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Radiopharm Theranostics's industry, Biotech Stocks , is 36.05%, which Radiopharm Theranostics exceeds.

Does Blackrock own Radiopharm Theranostics?

BlackRock is not among the top 10 institutional shareholders of Radiopharm Theranostics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools